Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013

MLA

Gamougam, Kadidja, et al. “Continuing Effectiveness of Serogroup a Meningococcal Conjugate Vaccine, Chad, 2013.” Emerging Infectious Diseases, Jan. 2015, p. 115. EBSCOhost, https://doi.org/10.3201/eid2101.140256.

APA

Gamougam, K., Daugla, D. M., Toralta, J., Ngadoua, C., Fermon, F., Page, A.-L., Djingarey, M. H., Caugant, D. A., Manigart, O., Trotter, C. L., Stuart, J. M., & Greenwood, B. M. (2015). Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013. Emerging Infectious Diseases, 115. https://doi.org/10.3201/eid2101.140256

Chicago

Gamougam, Kadidja, Doumagoum M. Daugla, Jacques Toralta, Cyriaque Ngadoua, Florence Fermon, Anne-Laure Page, Mamoudou H. Djingarey, et al. 2015. “Continuing Effectiveness of Serogroup a Meningococcal Conjugate Vaccine, Chad, 2013.” Emerging Infectious Diseases, January, 115. doi:10.3201/eid2101.140256.